Filter posts

Tackling Hepatitis C Hand in Hand with Communities

“For years of my life, I’ve let myself be defined by the words of others. …

Discrimination Against Vulnerable Patients Is Nothing New

Transformative therapies are advancing like never before, and a new class of medicines are changing …

New Videos Show How “Fail First” Policies Can Fail Patients

Continued access to a stable treatment can make all the difference for patients with chronic …

FDA Protects Patients While Promoting Innovation

Today, 83 percent of children with cancer survive, compared to just 58 percent in the …

Hepatitis C Has a Cure — Now Insurers Just Need to Pay for It

Today is World Hepatitis Day. In The Hill newspaper, BIO CEO Jim Greenwood argues that …

Let’s Thank the Innovators this World Hepatitis Day

In the United States alone there are 200,000 to 3 million cases of Hepatitis C …

WSJ Editorial: The Medical Innovation Threat

An editorial in today’s Wall Street Journal looks at the rising threat the American insurance industry’s …

Jim Greenwood in WSJ: Curing Hepatitis C Is Cheaper Than Open-Ended Care

On Friday, a letter from BIO President and CEO Jim Greenwood was published in the …

New study shows hepatitis C burden may ease in future

Anew study published in the Annals of Internal Medicine projects that the prevalence of hepatitis …